NanoString Technologies Inc (NSTG)

16.10
0.23 1.45
NASDAQ : Health Care
Prev Close 15.87
Open 15.90
Day Low/High 15.83 / 16.14
52 Wk Low/High 11.30 / 19.81
Volume 90.00K
Avg Volume 187.40K
Exchange NASDAQ
Shares Outstanding 25.20M
Market Cap 399.49M
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NanoString Technologies Enters Oversold Territory (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NanoString And Lam Research Announce Strategic Development Collaboration To Advance Hyb & Seq Next Generation Sequencing Platform

NanoString And Lam Research Announce Strategic Development Collaboration To Advance Hyb & Seq Next Generation Sequencing Platform

Partnership Brings Together Leaders in Nanoscale Technology and Molecular Profiling

Relative Strength Alert For NanoString Technologies

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NanoString Technologies is Now Oversold (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy NanoString Technologies At $17.50, Earn 14.7% Annualized Using Options

Investors eyeing a purchase of NanoString Technologies Inc shares, but cautious about paying the going market price of $19.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $17.50 strike, which has a bid at the time of this writing of $1.35.

Digital Spatial Profiling Technology Enables Quantitative Protein Profiling In FFPE Tissue Providing Detailed Molecular Characterization Of Immune Response To Tumors

The Yale School of Medicine Presents Validation of NanoString's Novel Digital Spatial Profiling Technology by Quantitative Immunofluorescence Technology at 2017 American Association for Cancer Research

NanoString Launches Multiple New Products At AACR 2017 To Advance Precision Oncology Research

New Offerings Include nCounter Platform Enhancements as Well as New Panels That Expand NanoString's Footprint in Immuno-oncology and 3D Biology Research

NanoString Highlights A Record Number Of NCounter-Based Research Abstracts In Precision Oncology And Predictive Biomarkers At The 2017 American Association Of Cancer Research (AACR) Annual Meeting

More than 45 Abstracts Demonstrate the Unique Capabilities of the nCounter Analysis System for Disease Characterization in Cancer Research and Immuno-Oncology

NanoString Launches New PlexSet Technology As An Alternative To QPCR For Multiplexed High-Throughput Gene Expression Studies

PlexSet's Simple Workflow Enables High-Plex Expression Analysis and Reduces Hands-on Time as Compared to qPCR

NanoString Technologies Releases Fourth Quarter And Full Year 2016 Operating Results And Provides 2017 Outlook

Highlights for 2016 Include 38% Revenue Growth, Two New Major Biopharma Diagnostic Collaborations and Substantial Progress on Pipeline of New Products and Technologies

The Novartis Institutes For BioMedical Research And NanoString Technologies Demonstrate A Novel Approach For High-Plex, Spatial Profiling Of Proteins Using NCounter-Based Digital Quantification At 2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Digital Spatial Profiling Technology Enables Spatially-Resolved, Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Tumors

TheStreet Quant Rating: D (Sell)